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Genetic screens in Drosophila have come a long way since the pioneering work of Nu¨sslein-Volhard and
Wieschaus. A recent paper by Mummery-Widmer et al. illustrates the use of genome-wide RNAi-based
reverse genetic screens in vivo and systems biology approaches to identify new components of the Notch
signaling pathway.
In his undergraduate lecture on introduc-
tory biology at MIT, Eric Lander introduces
the two fundamentallydifferentapproaches
to studying biology, genetics andbiochem-
istry, in the following way: the geneticist
studies an organism minus one gene. The
biochemist studies a protein minus an
organism. Some 40 years ago, molecular
biology and gene cloning connected
mutated genes and encoded proteins and
provided a basis for identifying the
fundamentalmechanismsof cell anddevel-
opmental biology. The latest and techno-
logically most advanced tour de force
genetic screen directed at understanding
Notch signaling during development has
just been published in Nature (Mummery-
Widmer et al., 2009). As well as being
impressive in its own right, this study
provides a prompt to review the advan-
tages and disadvantages of the different
genetic screens used over time, and ask
what else is needed to take us from
describing basic biological mechanisms to
understanding how the genome of an indi-
vidual species specifies its phenotype
(e.g., its precise size and shape).
Our understanding of the mechanisms
underlying the development of multicel-
lular organisms started to grow exponen-
tially with the pioneering Drosophila
embryonic lethal genetic screen carried
out by Christiane Nu¨sslein-Volhard and
EricWieschaus almost 30 years ago (Nu¨s-
slein-Volhard and Wieschaus, 1980). At
the time, this approach was greeted with
great skepticism by the Drosophila
community, and ‘‘mindless’’ screening
was also regarded by many as not really
being intellectual science. Together with
the work on homeotic genes by Edward
Lewis, Nu¨sslein-Volhard and Wieschaus
proved the skeptics wrong and provided
a foundation for understanding how the
body plan of insects and vertebrates is
laid out. Since then, whole-genome
screens have been conducted in almost
endless variations and have contributed
to our present-day understanding of
fundamental biological mechanisms. The
discovery of RNA interference (RNAi) has
opened up genetic dissection of biological
processes in organisms less genetically
tractable than Drosophila and C. elegans.
At this point, the ‘‘organism-minus-one-
gene’’ approach can be used in mamma-
lian cells, in tissues, and in entire organ-
isms. Even in Drosophila, the availability
of a genome-wide collection of transgenic
inducible RNAi lines has provided a new
dimension in genetic resolution. In their
new paper, Mummery-Widmer et al.
(2009) demonstrated the power of this
new approach by applying it to the Notch
pathway.
To expand our understanding of Notch
signaling, the authors chose to use
external sensory organs, the bristles on
the back of the fly, to screen for Notch
signaling components. It is known that
Notch acts twice during the development
of each bristle organ—first, to ensure that
from each group of putative sensory
organ precursor cells (SOP), only one is
selected as an SOP cell, and second, to
ensure that during the two asymmetric
divisions of the SOP, the four cells of the
bristle organ (socket, shaft, neuron, and
sheath cell) are correctly specified. Based
on the phenotypes of known Notch
pathway mutants, they classified the
phenotypes of lines with RNA hairpin
expression induced in the region where
bristle organs develop into basic pheno-
typic classes: defects in asymmetric cell
division (226 genes) and lateral inhibition
(233 genes). For 201 lines in this latter
class, RNA hairpin expression was also
induced in the wing as a test for general
Notch regulation, which narrowed the
pool down to 23 genes not previously
implicated in Notch signaling. Using
a reporter line for Notch target genes,
these 23 regulators were further classified
according to whether they act upstream
of Suppressor of Hairless, the key tran-
scription factor in the Notch signaling
pathway. Similarly, reporter lines were
used to determine whether ‘‘loss of
bristle’’ phenotypes were caused by the
failure to select SOPs or by defects in
asymmetric division. With this detailed
phenotypic and genetic characterization
in hand, the authors then integrated exist-
ing interaction data from yeast two-hybrid
screens, biochemistry, and genetics
using MCODE (Bader and Hogue, 2003)
to construct a Notch signaling network
of 177 genes with 780 interactions.
Many of the highly interconnected nodes
represent known protein complexes
involved in Notch modification, signaling,
and transcriptional output. The validity of
these complexes was confirmed by func-
tional testing of additional members. This
unprecedented resolution of Notch
signaling in vivo also highlights the role
of components involved in vesicle trans-
port and in ubiquitinylation of Notch and
other signaling components.
The paper by Mummery-Widmer and
colleagues is an impressive demonstration
of the power of the whole-genome, tissue-
or cell-type-specific RNAi screens that are
now possible in Drosophila. One of the
main advantages of this type of reverse
genetic screen relative to classical forward
genetic screens is that the targeted gene is
already known, which eliminates the need
tomapthemutation. It isalsomorestraight-
forward to assay multiple phenotypes at
once, as one can always go back to the
same gene or its RNAi line. For a more
detailed characterization of different
genetic screening methods, see Table 1.
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At this point, the technology and
resources for similar RNAi-based screens
in other organisms, including C. elegans
and the mouse, are simply not available.
It is likely that many of the 23 new gene
products that play a role in Notch
signaling are conserved during evolution
and that they play a similar role in verte-
brates. But what have we learnt beyond
that? Can we now predict or model how
the Notch switch between two cell fates
is thrown? Even this sophisticated
organism-minus-one-gene approach has
only given us a resolution of minus 600
million years, the time of the last common
ancestor between vertebrates and inver-
tebrates. We still need to understand
how the activity of these conserved path-
ways (e.g., Notch) controls the different
sizes and shapes of species and the vari-
ation within species. To attain this impor-
tant goal, we have to move away from the
single-gene approach and study the inter-
action between these conserved gene
and signaling networks in a quantitative
way. One of the promises of systems
biology is that emergent properties within
these networks will help us to understand
fundamental differences between biolog-
ical systems. To attain this next level of
understanding, not only do we need
quantitative data sets of RNA and protein
expression and modification in time and
space, we will also need computational
tools to integrate and model these inter-
actions. Such computational models
must also include the physical properties
of cells and tissues, and must make
predictions that can be tested experimen-
tally with tools such as an RNAi library that
enables simultaneous knockdown of
multiple genes.
Because natural and artificial selection
acts on cellular networks and not on
individual genes, complementary informa-
tion will come from population genetics.
The rapidly decreasing cost of DNA
sequencing permits the accumulation of
large numbers of DNA sequences. With
the ‘‘$1000 genome’’ being only a few
years away, this even applies to humans.
Unlike model organisms, humans will be
able to contribute detailed phenotypic
information, permitting a high-resolution
mappingofphenotype togenotype.Taking
this approach together with the detailed
understanding from the single-gene
genetic approaches in model organisms,
we can be optimistic about understanding
and modeling biological processes and
diseases in more quantitative and
complete ways in the future.
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Table 1. Comparison of Different Genetic Screening Methods
Type of Screen Mutagen/Effect Mapping Advantages Disadvantages
EMS screen for
recessive mutations
(Nu¨sslein-Volhard and
Wieschaus, 1980)
chemical
(EMS)
recombination
mapping and
complementation
analysis
d allelic series
d point mutations identify
functional domains in protein
d F3 screen
d mapping tedious
d lines selected for a
specific phenotype
d lethality precludes analysis
of later phenotypes
Tissue-specific
EMS screen
using eye-Flp
(Newsome et al.,
2000; Gluderer
et al., 2008)
chemical
(EMS)
recombination
mapping and
complementation
analysis
d F1 screen (>10-fold genome
saturation possible)
d genetic mosaics circumvent
problems with organismal lethality
d allelic series
d point mutations identify
functional domains in protein
d slow (e.g. 10 person years
for 10-fold saturation of
genome for growth mutants)
d mapping tedious
d lines selected for
a specific phenotype
Tissue-specfic
RNAi screen
(Dietzl et al., 2007)
RNA
interference
no mapping
necessary
d F1 screen
d no mapping required
d forward screen permits
recording multiple phenotypes
d targeted gene knockdown
controlled by Gal4 line
(also possible in postmitotic cells)
d fast (6 person years for entire screen
and characterization of mutants)
d gene inactivation
often not complete
d no allelic series
d no information about
functional domains
of the protein
d activation of the RNA
interference response
d off-target effects
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